395 related articles for article (PubMed ID: 3510719)
1. Macrophage tumoricidal activity as a possible antitumor mechanism associated with the local injection of allogeneic spleen cells into rats.
Kawase I; Komuta K; Namba M; Yokota S; Ogura T; Kishimoto S
Cancer Res; 1986 Mar; 46(3):1047-54. PubMed ID: 3510719
[TBL] [Abstract][Full Text] [Related]
2. Effector mechanism in concomitant immunity potentiated by intratumoral injection of Nocardia rubra cell wall skeleton.
Ogura T; Hara H; Yokota S; Hosoe S; Kawase I; Kishimoto S; Yamamura Y
Cancer Res; 1985 Dec; 45(12 Pt 1):6371-5. PubMed ID: 4063987
[TBL] [Abstract][Full Text] [Related]
3. [Induction of activated macrophages by intraperitoneal injection of mitomycin C in mice and rats].
Ogura T
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):689-96. PubMed ID: 3083782
[TBL] [Abstract][Full Text] [Related]
4. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
Nakajima H; Fujiwara H; Takai Y; Izumi Y; Sano S; Tsuchida T; Hamaoka T
J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520
[TBL] [Abstract][Full Text] [Related]
5. Association of macrophage activation with antitumor effect on rat syngeneic fibrosarcoma by Nocardia rubra cell wall skeleton.
Ogura T; Namba N; Hirao F; Yamamura Y; Azuma I
Cancer Res; 1979 Nov; 39(11):4706-12. PubMed ID: 498096
[TBL] [Abstract][Full Text] [Related]
6. Possible participation of tumoricidal macrophages in the therapeutic effect of bleomycin on a transplantable rat fibrosarcoma.
Morikawa K; Hosokawa M; Hamada J; Xu ZY; Kobayashi H
Cancer Res; 1986 Feb; 46(2):684-8. PubMed ID: 2416431
[TBL] [Abstract][Full Text] [Related]
7. [Enhancement of antitumor immune responses by bleomycin].
Morikawa K
Hokkaido Igaku Zasshi; 1988 Sep; 63(5):772-80. PubMed ID: 2467868
[TBL] [Abstract][Full Text] [Related]
8. Effect of Nocardia rubra cell wall skeleton on T-cell-mediated cytotoxicity in mice bearing syngeneic sarcoma.
Kawase I; Uemiya M; Yoshimoto T; Ogura T; Hirao F; Yamamura Y
Cancer Res; 1981 Feb; 41(2):660-6. PubMed ID: 6969630
[TBL] [Abstract][Full Text] [Related]
9. Influence of surgical removal and effect of levamisole on cytotoxic T-cell-mediated antitumor immunity in mice.
Gomi K; Morimoto M; Nomoto K
Cancer Res; 1983 Nov; 43(11):5120-5. PubMed ID: 6604572
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the in vitro cytolytic effect of hepatic, splenic and peritoneal macrophages from glucan-treated mice on sarcoma M5076.
Sherwood ER; Williams DL; Di Luzio NR
Methods Find Exp Clin Pharmacol; 1986 Mar; 8(3):157-61. PubMed ID: 3713379
[TBL] [Abstract][Full Text] [Related]
11. Activation of tumoricidal properties in mouse macrophages by lymphokines encapsulated in liposomes.
Poste G; Kirsh R; Fogler WE; Fidler IJ
Cancer Res; 1979 Mar; 39(3):881-92. PubMed ID: 427777
[TBL] [Abstract][Full Text] [Related]
12. B cell stimulatory factor-1 (interleukin 4) activates macrophages for increased tumoricidal activity and expression of Ia antigens.
Crawford RM; Finbloom DS; Ohara J; Paul WE; Meltzer MS
J Immunol; 1987 Jul; 139(1):135-41. PubMed ID: 3108395
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic T-cell-mediated antitumor effect of levamisole against murine syngeneic fibrosarcoma.
Gomi K; Morimoto M; Nomoto K
Cancer Res; 1982 Oct; 42(10):4197-202. PubMed ID: 6980702
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy of murine sarcoma by adoptive transfer of resident peritoneal macrophages proliferating in culture.
Bartholeyns J; Lombard Y; Poindron P
Anticancer Res; 1988; 8(1):145-51. PubMed ID: 3358630
[TBL] [Abstract][Full Text] [Related]
15. Tolerance induction to cardiac allografts by simultaneous or sequential intrathymic inoculation of disparate alloantigens.
Shimomura K; Hardy MA; Oluwole SF
Transplantation; 1995 Oct; 60(8):806-11. PubMed ID: 7482739
[TBL] [Abstract][Full Text] [Related]
16. In vivo activity of lymphokine-activated macrophages in host defense against neoplasia.
Fernandez-Cruz E; Ulich T; Schreiber RD
J Immunol; 1985 May; 134(5):3489-96. PubMed ID: 3920323
[TBL] [Abstract][Full Text] [Related]
17. Cyclophosphamide-induced appearance of immunopotentiating T-cells in the spleens of mice bearing a large MOPC-315 tumor.
Ye QW; Mokyr MB
Cancer Res; 1984 Sep; 44(9):3873-9. PubMed ID: 6611201
[TBL] [Abstract][Full Text] [Related]
18. Requirements of adherent cells for activating Lyt-1+2- T cells as well as for functioning as antitumor effectors activated by factor(s) from Lyt-1+2- T cells.
Sakamoto K; Fujiwara H; Nakajima H; Yoshioka T; Takai Y; Hamaoka T
Jpn J Cancer Res; 1986 Nov; 77(11):1142-52. PubMed ID: 3098724
[TBL] [Abstract][Full Text] [Related]
19. [Influences of inflammatory macrophages on the proliferation of mouse tumor cells in vitro].
Sun DM; Hu XZ; Shi W; Zhang YH
Zhonghua Zhong Liu Za Zhi; 1986 Jul; 8(4):247-9. PubMed ID: 3093180
[TBL] [Abstract][Full Text] [Related]
20. Anti-tumor activity of recombinant tumor necrosis factor on mouse fibrosarcoma in vivo and in vitro.
Tomazic VJ; Farha M; Loftus A; Elias EG
J Immunol; 1988 Jun; 140(11):4056-61. PubMed ID: 3372997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]